Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Vaccine|October 4, 2011
Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virusFelix W Santiago, Theresa Fitzgerald, John J Treanor, et al.
Infection Control and Hospital Epidemiology|June 11, 2014
Maintain the gain: program to sustain performance improvement in environmental cleaningMark E Rupp, Theresa Fitzgerald, Lee Sholtz, et al.
Vaccine|May 22, 2012
Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systemsFelix W Santiago, Kris Lambert Emo, Theresa Fitzgerald, et al.
American Journal of Infection Control|December 2, 2004
Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistanceMark E Rupp, Theresa Fitzgerald, Nedra Marion, et al.
The Journal of Infectious Diseases|December 15, 2015
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)Mahdee Sobhanie, Yumiko Matsuoka, Sinthujan Jegaskanda, et al.
Immunology|February 9, 2016
Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protectionMarta L DeDiego, Christopher S Anderson, Hongmei Yang, et al.
Viruses|January 22, 2021
Gaps in Serologic Immunity against Contemporary Swine-Origin Influenza A Viruses among Healthy Individuals in the United StatesJoshua N Lorbach, Theresa Fitzgerald, Carolyn Nolan, et al.
Vaccine|May 21, 2011
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)David N Taylor, John J Treanor, Cynthia Strout, et al.
Vaccine|December 3, 2014
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccineTara M Babu, Min Levine, Theresa Fitzgerald, et al.
Vaccine|October 26, 2010
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adultsJohn J Treanor, David N Taylor, Lynda Tussey, et al.
Pageof 3